phrykt

Alnylam Pharmaceuticals, Inc. (ALNY): who owns it and who trades it

As of Nov 16, 2026, ALNY insiders reported 199 open-market sales worth $28.7M and 2 purchases worth $543K in the last 12 months, with 53% of the sale value made under pre-set 10b5-1 plans. The largest seller was Yvonne Greenstreet (CEO), with $8.8M. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Alnylam Pharmaceuticals

From the latest filings

Overall: more selling than buying. Insiders and Congress mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns ALNY

785 funds and institutions reported ALNY shares worth $40.3B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is FMR LLC (Fidelity) with 11.3%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

FMR LLC (Fidelity)11.3%
Capital World Investors8.4%
BlackRock, Inc.8.2%
Capital Research Global Investors7.4%
Vanguard Portfolio Management LLC4.9%
Vanguard Capital Management LLC4.5%
T. Rowe Price Investment Management, Inc.4.3%
Invesco Ltd.2.8%
State Street Corp2.7%
JPMorgan Chase & Co2.0%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
FMR LLC (Fidelity)15.02M11.33%$4.5B+3%
Capital World Investors11.14M8.40%$3.4B+3%
BlackRock, Inc.10.91M8.22%$3.3B+4%
Capital Research Global Investors9.75M7.35%$2.9B+3%
Vanguard Portfolio Management LLC6.54M4.93%$2B+1%
Vanguard Capital Management LLC6.03M4.55%$1.8B+1%
T. Rowe Price Investment Management, Inc.5.64M4.25%$1.7B+9%
Invesco Ltd.3.75M2.83%$1.1B+191%
State Street Corp3.56M2.68%$1.1B+7%
JPMorgan Chase & Co2.68M2.02%$785M–
Geode Capital Management, LLC2.64M1.99%$791M-1%
Baillie Gifford & Co2.44M1.84%$734M-2%
Norges Bank2.27M1.71%$684M–
Wellington Management Group LLP2.11M1.59%$635M+9%
Orbis Allan Gray Ltd1.99M1.50%$598M+49%
Dodge & Cox1.96M1.47%$589M+1%
Two Sigma Investments, LP1.88M1.41%$565M-6%
American Century Companies Inc1.85M1.40%$558M+3%
Clearbridge Investments, LLC1.26M0.95%$379M-7%
T. Rowe Price Associates1.15M0.87%$346M-20%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, ALNY insiders reported $543K of open-market purchases and $28.7M of sales. 53% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$543K
2 trades, 2 people
Sales, 12 months
$28.7M
199 trades, 8 people
Sales under a 10b5-1 plan
53%
Share of sale value
Latest trade
Nov 10, 2026
Filed Nov 12, 2026

Purchases and sales by month

$8.8M$8.8MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 10, 2026Charles Elliott SigalDirectorPurchase1,600$152.25$244KForm 4
Nov 9, 2026Amy W SchulmanDirectorPurchase1,910$156.82$300KForm 4
Oct 2, 2026Bryan SupranVice presidentSale1,758$226.88$399KForm 4
Jun 1, 2026David E I PyottDirectorSale plan1,175$298.91$351KForm 4
Jun 1, 2026David E I PyottDirectorSale plan17$302.65$5.1KForm 4
Jun 1, 2026David E I PyottDirectorSale plan921$297.71$274KForm 4
Jun 1, 2026David E I PyottDirectorSale plan495$300.72$149KForm 4
Jun 1, 2026David E I PyottDirectorSale plan1,222$299.87$366KForm 4
Apr 6, 2026Melissa McLaughlinChief Human Resources OfSale plan199$333.94$66.5KForm 4
Apr 6, 2026Melissa McLaughlinChief Human Resources OfSale plan293$331.89$97.2KForm 4
Apr 6, 2026Melissa McLaughlinChief Human Resources OfSale plan829$330.46$274KForm 4
Apr 6, 2026Melissa McLaughlinChief Human Resources OfSale plan909$329.76$300KForm 4
Apr 6, 2026Melissa McLaughlinChief Human Resources OfSale plan56$320.14$17.9KForm 4
Apr 2, 2026Melissa McLaughlinChief Human Resources OfSale plan209$318.47$66.6KForm 4
Apr 2, 2026Melissa McLaughlinChief Human Resources OfSale plan265$316.61$83.9KForm 4
Apr 2, 2026Melissa McLaughlinChief Human Resources OfSale plan359$317.44$114KForm 4
Apr 2, 2026Melissa McLaughlinChief Human Resources OfSale plan8$325.49$2.6KForm 4
Apr 2, 2026Melissa McLaughlinChief Human Resources OfSale plan81$323.64$26.2KForm 4
Apr 2, 2026Melissa McLaughlinChief Human Resources OfSale plan86$319.69$27.5KForm 4
Apr 2, 2026Melissa McLaughlinChief Human Resources OfSale plan224$321.64$72KForm 4
Apr 2, 2026Melissa McLaughlinChief Human Resources OfSale plan245$322.86$79.1KForm 4
Apr 2, 2026Melissa McLaughlinChief Human Resources OfSale plan147$320.62$47.1KForm 4
Mar 5, 2026Pushkal GargVice presidentSale plan500$326.08$163KForm 4
Mar 5, 2026Pushkal GargVice presidentSale plan510$324.59$166KForm 4
Mar 5, 2026Pushkal GargVice presidentSale plan740$323.55$239KForm 4
Mar 5, 2026Pushkal GargVice presidentSale plan654$322.33$211KForm 4
Mar 5, 2026Kevin Joseph FitzgeraldVice presidentSale plan124$321.81$39.9KForm 4
Mar 5, 2026Kevin Joseph FitzgeraldVice presidentSale plan233$323.25$75.3KForm 4
Mar 5, 2026Kevin Joseph FitzgeraldVice presidentSale plan148$324.60$48KForm 4
Mar 5, 2026Kevin Joseph FitzgeraldVice presidentSale plan153$326.24$49.9KForm 4
Mar 4, 2026Pushkal GargVice presidentSale plan106$319.03$33.8KForm 4
Mar 4, 2026Pushkal GargVice presidentSale plan102$320.01$32.6KForm 4
Mar 4, 2026Pushkal GargVice presidentSale plan208$325.67$67.7KForm 4
Mar 4, 2026Pushkal GargVice presidentSale plan272$324.88$88.4KForm 4
Mar 4, 2026Pushkal GargVice presidentSale plan767$323.84$248KForm 4
Mar 4, 2026Pushkal GargVice presidentSale plan350$323.01$113KForm 4
Mar 4, 2026Pushkal GargVice presidentSale plan289$321.82$93KForm 4
Mar 4, 2026Pushkal GargVice presidentSale plan215$320.81$69KForm 4
Mar 4, 2026Yvonne GreenstreetCEOSale973$323.84$315KForm 4
Mar 4, 2026Yvonne GreenstreetCEOSale444$323.01$143KForm 4
Mar 4, 2026Yvonne GreenstreetCEOSale368$321.82$118KForm 4
Mar 4, 2026Yvonne GreenstreetCEOSale274$320.81$87.9KForm 4
Mar 4, 2026Yvonne GreenstreetCEOSale265$325.67$86.3KForm 4
Mar 4, 2026Yvonne GreenstreetCEOSale135$319.03$43.1KForm 4
Mar 4, 2026Yvonne GreenstreetCEOSale345$324.88$112KForm 4
Mar 4, 2026Yvonne GreenstreetCEOSale129$320.01$41.3KForm 4
Mar 4, 2026Jeffrey V. PoultonCFOSale114$319.03$36.4KForm 4
Mar 4, 2026Jeffrey V. PoultonCFOSale109$320.01$34.9KForm 4
Mar 4, 2026Jeffrey V. PoultonCFOSale223$325.67$72.6KForm 4
Mar 4, 2026Jeffrey V. PoultonCFOSale818$323.84$265KForm 4
Mar 4, 2026Jeffrey V. PoultonCFOSale291$324.88$94.5KForm 4
Mar 4, 2026Jeffrey V. PoultonCFOSale230$320.81$73.8KForm 4
Mar 4, 2026Jeffrey V. PoultonCFOSale309$321.82$99.4KForm 4
Mar 4, 2026Jeffrey V. PoultonCFOSale374$323.01$121KForm 4
Mar 4, 2026Kevin Joseph FitzgeraldVice presidentSale plan29$319.03$9.3KForm 4
Mar 4, 2026Kevin Joseph FitzgeraldVice presidentSale plan96$323.01$31KForm 4
Mar 4, 2026Kevin Joseph FitzgeraldVice presidentSale plan210$323.84$68KForm 4
Mar 4, 2026Kevin Joseph FitzgeraldVice presidentSale plan75$324.88$24.4KForm 4
Mar 4, 2026Kevin Joseph FitzgeraldVice presidentSale plan57$325.67$18.6KForm 4
Mar 4, 2026Kevin Joseph FitzgeraldVice presidentSale plan28$320.01$9KForm 4
Mar 4, 2026Kevin Joseph FitzgeraldVice presidentSale plan79$321.82$25.4KForm 4
Mar 4, 2026Kevin Joseph FitzgeraldVice presidentSale plan59$320.81$18.9KForm 4
Mar 3, 2026Pushkal GargVice presidentSale plan355$316.74$112KForm 4
Mar 3, 2026Pushkal GargVice presidentSale plan317$319.06$101KForm 4
Mar 3, 2026Pushkal GargVice presidentSale plan640$320.48$205KForm 4
Mar 3, 2026Pushkal GargVice presidentSale plan463$321.50$149KForm 4
Mar 3, 2026Kevin Joseph FitzgeraldVice presidentSale plan289$316.55$91.5KForm 4
Mar 3, 2026Kevin Joseph FitzgeraldVice presidentSale plan282$318.62$89.9KForm 4
Mar 3, 2026Kevin Joseph FitzgeraldVice presidentSale plan722$320.51$231KForm 4
Mar 3, 2026Kevin Joseph FitzgeraldVice presidentSale plan359$321.58$115KForm 4
Mar 2, 2026Jeffrey V. PoultonCFOSale138$328.71$45.4KForm 4
Mar 2, 2026Jeffrey V. PoultonCFOSale234$329.71$77.2KForm 4
Mar 2, 2026Jeffrey V. PoultonCFOSale112$330.85$37.1KForm 4
Mar 2, 2026Jeffrey V. PoultonCFOSale129$331.93$42.8KForm 4
Mar 2, 2026Jeffrey V. PoultonCFOSale53$332.64$17.6KForm 4
Mar 2, 2026Jeffrey V. PoultonCFOSale541$326.81$177KForm 4
Mar 2, 2026Jeffrey V. PoultonCFOSale65$323.62$21KForm 4
Mar 2, 2026Jeffrey V. PoultonCFOSale124$324.65$40.3KForm 4
Mar 2, 2026Jeffrey V. PoultonCFOSale356$325.63$116KForm 4
Mar 2, 2026Jeffrey V. PoultonCFOSale454$327.67$149KForm 4
Mar 2, 2026Pushkal GargVice presidentSale plan97$324.65$31.5KForm 4
Mar 2, 2026Pushkal GargVice presidentSale plan421$326.81$138KForm 4
Mar 2, 2026Pushkal GargVice presidentSale plan353$327.67$116KForm 4
Mar 2, 2026Pushkal GargVice presidentSale plan107$328.71$35.2KForm 4
Mar 2, 2026Pushkal GargVice presidentSale plan182$329.71$60KForm 4
Mar 2, 2026Pushkal GargVice presidentSale plan87$330.85$28.8KForm 4
Mar 2, 2026Pushkal GargVice presidentSale plan101$331.93$33.5KForm 4
Mar 2, 2026Pushkal GargVice presidentSale plan42$332.64$14KForm 4
Mar 2, 2026Pushkal GargVice presidentSale plan50$323.62$16.2KForm 4
Mar 2, 2026Pushkal GargVice presidentSale plan277$325.63$90.2KForm 4
Mar 2, 2026Kevin Joseph FitzgeraldVice presidentSale plan37$332.64$12.3KForm 4
Mar 2, 2026Kevin Joseph FitzgeraldVice presidentSale plan94$331.93$31.2KForm 4
Mar 2, 2026Kevin Joseph FitzgeraldVice presidentSale plan81$330.85$26.8KForm 4
Mar 2, 2026Kevin Joseph FitzgeraldVice presidentSale plan170$329.71$56.1KForm 4
Mar 2, 2026Kevin Joseph FitzgeraldVice presidentSale plan100$328.71$32.9KForm 4
Mar 2, 2026Kevin Joseph FitzgeraldVice presidentSale plan329$327.67$108KForm 4
Mar 2, 2026Kevin Joseph FitzgeraldVice presidentSale plan392$326.81$128KForm 4
Mar 2, 2026Kevin Joseph FitzgeraldVice presidentSale plan258$325.63$84KForm 4
Mar 2, 2026Kevin Joseph FitzgeraldVice presidentSale plan90$324.65$29.2KForm 4
Mar 2, 2026Kevin Joseph FitzgeraldVice presidentSale plan47$323.62$15.2KForm 4

Latest 100 of 201 trades in the last 12 months.

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Yvonne GreenstreetChief Executive Officer, Director–$8.8MMar 4, 2026
Kevin Joseph FitzgeraldCSO & EVP, Head of Research–$8.5MMar 5, 2026
Pushkal GargEVP Chief R&D–$5.4MMar 5, 2026
Jeffrey V. PoultonEVP, Chief Financial Officer–$2.5MMar 4, 2026
Melissa McLaughlinChief Human Resources Officer–$1.3MApr 6, 2026
David E I PyottDirector–$1.1MJun 1, 2026
Tolga TangulerEVP, Chief Commercial Officer–$615KFeb 13, 2026
Bryan SupranEVP, CLO and Secretary–$399KOct 2, 2026
Amy W SchulmanDirector$300K–Nov 9, 2026
Charles Elliott SigalDirector$244K–Nov 10, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ALNY short interest

Low short interest. 4.1% of ALNY shares are sold short: about 1 share in 25. Over the last 12 reports the number of shares short went up 1%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 5.47M ALNY shares were sold short, 4.1% of the shares outstanding, down 16.8% from the report before. At the average daily volume of 2.87M shares, buying them all back would take about 1.9 trading days (days to cover).

Shares short, % of all shares

4.08%May 15Oct 306.09%

Days to cover

1.9May 15Oct 307.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20265.47M4.08%-17%2.87M1.9
Oct 15, 20266.57M4.91%-15%1.29M5.1
Sep 30, 20267.71M5.76%+7%1.20M6.5
Sep 15, 20267.19M5.38%+13%1.74M4.1
Aug 31, 20266.34M4.74%+33%1.63M3.9
Aug 14, 20264.77M3.57%-1%2.02M2.4
Jul 31, 20264.80M3.59%-17%2.20M2.2
Jul 15, 20265.77M4.35%-0%1.78M3.2
Jun 30, 20265.80M4.37%+7%1.37M4.2
Jun 15, 20265.44M4.10%+3%1.14M4.8
May 29, 20265.30M4.00%-2%917,6375.8
May 15, 20265.40M4.07%+13%1.05M5.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded ALNY

Since Nov 17, 2024, 2 members of Congress reported 0 purchases and 2 sales of ALNY. The latest was a sale by Cory A. Booker on Aug 11, 2026, reported Sep 9, 2026.

Purchases 0Sales 2

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Aug 11, 2026Cory A. Booker (D-NJ)Sale$1K–$15KSpouseSep 9, 2026Report
May 12, 2025Jefferson Shreve (R-IN)Sale$15K–$50KSelfJun 22, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Alnylam Pharmaceuticals company events

Alnylam Pharmaceuticals filed 10 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Nov 5, 2026.

  1. Nov 5, 2026LeadershipAlnylam Pharmaceuticals, Inc. announced that Tolga Tanguler will depart from his role as the Company’s Executive Vice President, Chief Commercialization Officer in December 2026. Filing
  2. Oct 29, 2026ResultsReleased financial results. Filing
  3. Jul 30, 2026ResultsReleased financial results. Filing
  4. May 27, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. Filing
  5. Apr 30, 2026ResultsReleased financial results. Filing
  6. Mar 4, 2026LeadershipThe Board of Directors of Alnylam Pharmaceuticals, Inc. granted, following the recommendation of the People, Culture and Compensation Committee, a special equity award under the Company’s Second Amended and Restated 2018 Stock Incentive Plan to Yvonne Greenstreet, M.D., M.B.A., the Company’s Chief… Filing
  7. Feb 12, 2026ResultsReleased financial results. Filing
  8. Jan 12, 2026ResultsReleased financial results. Filing
  9. Dec 11, 2025AnnouncementAlnylam Pharmaceuticals, Inc. entered into separate, privately negotiated repurchase agreements with certain holders of its 1.00% convertible senior notes due 2027 to repurchase for cash approximately $34.4 million of the Notes for a total repurchase cost (including accrued and unpaid interest) of… Filing
  10. Dec 3, 2025LeadershipMichael W. Bonney and Carolyn Bertozzi, Ph.D. provided notice of each of their resignations from the Board of Directors of Alnylam Pharmaceuticals, Inc., effective on the same date. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Alnylam Pharmaceuticals financials

Famous investors that hold ALNY

3 of the 50 well-known investors we track reported holding ALNY in their latest 13F filing. The largest position is Israel Englander's, worth $93.2M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 2026377,728$93.2M0.1%+20%
Ray Dalio · Bridgewater AssociatesQ3 202628,463$7M0.0%-71%
Lee Ainslie · Maverick CapitalQ3 2026907$224K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 10 filings named ALNY in the last 120 days.

FiledHolderFormStake
Nov 16, 2026T. Rowe Price Investment Management, Inc.13G7.5%
Nov 16, 2026T. Rowe Price Investment Management, Inc.13G7.5%
Nov 13, 2026Capital Research Global Investors13G/A8.2%
Nov 13, 2026Capital World Investors13G/A10.4%
Nov 13, 2026Capital Research Global Investors13G/A8.2%
Nov 13, 2026Capital World Investors13G/A10.4%
Nov 5, 2026FMR LLC13G/A9.5%
Nov 5, 2026FMR LLC13G/A9.5%
Oct 30, 2026Vanguard Portfolio Management13G5.0%
Oct 30, 2026Vanguard Portfolio Management13G5.0%

Questions about Alnylam Pharmaceuticals, Inc. (ALNY) stock

Who owns the most ALNY stock?

The largest reported owner of Alnylam Pharmaceuticals, Inc. (ALNY) is FMR LLC (Fidelity), with 11.3% of the company. In total, 785 funds and institutions reported holding ALNY at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are ALNY insiders buying or selling?

In the last 12 months, ALNY insiders reported 2 open-market purchases worth $543K and 199 sales worth $28.7M. The latest trade was on Nov 10, 2026. See every trade.

What is the short interest in ALNY?

As of Oct 30, 2026, 5.47M ALNY shares were sold short, 4.1% of the shares outstanding, down 16.8% from the report before. At the average daily volume of 2.87M shares, buying them all back would take about 1.9 trading days (days to cover). See the history.

Have members of Congress traded ALNY?

Yes. 2 members of Congress reported 0 purchases and 2 sales of ALNY since Nov 17, 2024. The latest was reported on Sep 9, 2026. See the trades.

Which famous investors hold ALNY?

3 of the 50 well-known investors we track reported ALNY in their latest 13F filing, including Israel Englander, Ray Dalio, Lee Ainslie. The largest position is worth $93.2M. See all holders.

Executive pay

Alnylam Pharmaceuticals's chief executive was paid a total of $14.9M for the year ended Dec 31, 2025, up 29% from $11.5M the year before. In the last 12 months, Alnylam Pharmaceuticals's executives and directors bought $543K of stock on the open market and sold $28.7M.

Chief executive, total pay$14.9MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$77.4MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$6.6MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.